These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7203769)

  • 1. Antimalarial therapy for lupus erythematosus: an apparent advantage of quinacrine.
    Zuehlke RL; Lillis PJ; Tice A
    Int J Dermatol; 1981; 20(1):57-61. PubMed ID: 7203769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus.
    Feldmann R; Salomon D; Saurat JH
    Dermatology; 1994; 189(4):425-7. PubMed ID: 7873836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
    González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
    Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine.
    TYE MJ; WHITE H; APPEL B; ANSELL HB
    N Engl J Med; 1959 Jan; 260(2):63-6. PubMed ID: 13613503
    [No Abstract]   [Full Text] [Related]  

  • 7. Discoid lupus erythematosus.
    Brown RK
    Arch Dermatol; 1972 May; 105(5):768-70. PubMed ID: 4537259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systemic lupus erythematosus therapy. Antimalarials in inflammatory diseases].
    Yebra-Bango M; Tutor-Ureta P
    Rev Clin Esp; 2004 Nov; 204(11):565-6. PubMed ID: 15511401
    [No Abstract]   [Full Text] [Related]  

  • 9. A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.
    Costedoat-Chalumeau N; Dunogué B; Leroux G; Morel N; Jallouli M; Le Guern V; Piette JC; Brézin AP; Melles RB; Marmor MF
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):317-26. PubMed ID: 25672591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous lupus erythematosus. Recognition of its many forms.
    Clark SK
    Postgrad Med; 1986 Apr; 79(5):195-203. PubMed ID: 3960799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
    Laaksonen AL; Koskiahde V; Juva K
    Scand J Rheumatol; 1974; 3(2):103-8. PubMed ID: 4608161
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimalarial drugs in the treatment of rheumatological diseases.
    Rynes RI
    Br J Rheumatol; 1997 Jul; 36(7):799-805. PubMed ID: 9255117
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimalarial agents and lupus.
    Wallace DJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular toxicity of antimalarial drugs. Long-term follow-up.
    Carr RE; Henkind P; Rothfield N; Siegel IM
    Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 17. The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients.
    Toubi E; Rosner I; Rozenbaum M; Kessel A; Golan TD
    Lupus; 2000; 9(2):92-5. PubMed ID: 10787004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus; a report on twelve cases treated with quinacrine (atabrine) and chloroquine (aralen).
    CONNER SK
    Ann Rheum Dis; 1957 Mar; 16(1):76-81. PubMed ID: 13412009
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
    Mittal L; Zhang L; Feng R; Werth VP
    J Am Acad Dermatol; 2018 Jan; 78(1):100-106.e1. PubMed ID: 28989103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic antimalarial drugs in chronic discoid lupus erythematosus and light eruptions.
    ROGERS J; FINN OA
    AMA Arch Derm Syphilol; 1954 Jul; 70(1):61-6. PubMed ID: 13170820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.